Smith & Nephew (Smith & Nephew) FCF Margin %

: 8.35% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Smith & Nephew's Free Cash Flow for the six months ended in Dec. 2023 was $235 Mil. Smith & Nephew's Revenue for the six months ended in Dec. 2023 was $2,815 Mil. Therefore, Smith & Nephew's FCF Margin % for the quarter that ended in Dec. 2023 was 8.35%.

As of today, Smith & Nephew's current FCF Yield % is 1.73%.

The historical rank and industry rank for Smith & Nephew's FCF Margin % or its related term are showing as below:

SNN' s FCF Margin % Range Over the Past 10 Years
Min: 2.11 Med: 10.29 Max: 14.98
Current: 3.26

During the past 13 years, the highest FCF Margin % of Smith & Nephew was 14.98%. The lowest was 2.11%. And the median was 10.29%.

SNN's FCF Margin % is ranked better than
66.22% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs SNN: 3.26

Smith & Nephew FCF Margin % Historical Data

The historical data trend for Smith & Nephew's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

14.79

10.79

9.00

2.11

3.26

Smith & Nephew Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %																10.75	1.31	2.91	-1.98	8.35

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew FCF Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's FCF Margin % falls into.

Smith & Nephew FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Smith & Nephew's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	181	/	5549
	=	3.26 %

Smith & Nephew's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	235	/	2815
	=	8.35 %

Smith & Nephew FCF Margin % Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.